You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 2, February 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (48)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Pulmonary Diseases, Other
 •Oncology
 •Alert me on articles by topic

Antiamphiphysin Antibodies Are Associated With Various Paraneoplastic Neurological Syndromes and Tumors

Jean Christophe Antoine, MD; Lena Absi, PhD; Jerome Honnorat, MD; Jean-Marc Boulesteix, MD; Thomas de Brouker, MD; Christophe Vial, MD; Margareth Butler, PhD; Pietro De Camilli, PhD; Daniel Michel, MD

Arch Neurol. 1999;56:172-177.

Background  Antiamphiphysin antibodies react with a 128-kd protein found in synaptic vesicles.They were first described in patients with paraneoplastic stiff-man syndrome and breast cancer, but studies suggest that they can also occur in patients with other tumors and neurological disorders.

Objective  To determine if antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors.

Patients and Methods  Of 2800 serum samples tested by routine immunohistochemical procedures on sections of paraformaldehyde-fixed rat brain for the detection of autoantibodies associated with paraneoplastic neurological syndromes, 5 were selected because of labeling suggestive of antiamphiphysin antibodies and subsequently confirmed by the results of Western blot analysis using recombinant amphiphysin protein. Controls consisted of 40 patients with various nonparaneoplastic neurological diseases; 101 patients with cancer but without paraneoplastic neurological syndrome; 9 patients with small cell lung cancer, anti-Hu antibodies, and paraneoplastic neurological syndrome; 3 patients with M2-type antimitochondrial antibodies but no neurological disorder; and 30 normal subjects.

Results  Of the 5 patients with antiamphiphysin antibodies, patient 1 had sensory neuronopathy, encephalomyelitis, and breast cancer; patient 2 had limbic encephalitis, and small cell lung cancer was detected in the mediastinum after 24 months of follow-up; patient 3 had encephalomyelitis and ovarian carcinoma; and patients 4 and 5 had Lambert-Eaton myasthenic syndrome and small cell lung cancer (patient 4 subsequently developed cerebellar degeneration). None of the 5 had stiffness. Two patients (Nos. 2 and 4) had antimitochondrial antibodies. The two patients (Nos. 4 and 5) with Lambert-Eaton myasthenic syndrome had antibodies directed against the voltage-gated calcium channel, and patient 2 subsequently developed anti-Hu antibodies. In the controls, antiamphiphysin antibodies were detected by Western blot analysis in 3 of 8 patients with anti-Hu antibodies, but in none of the other groups.

Conclusions  These data indicate that antiamphiphysin antibodies are not specific for one type of tumor or one neurological syndrome and can be associated with other neural and nonneural antibodies. The simultaneous association of several antibodies in some patients suggests multimodal autoantibody production.


From the Neurology Service, Hôpital de Bellevue, Saint-Etienne (Drs Antoine and Michel), Hôpital Neurologique, Lyon (Dr Honnorat), Centre Hospitalier, Cahors (Dr Boulesteix), and Hôpital de la Fontaine, Saint-Denis (Dr de Brouker), France; the Centre de Transfusion Sanguine, Saint-Etienne (Dr Absi); the Electromyography Service, Hôpital Neurologique, Lyon (Dr Vial); and the Department of Cell Biology and Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Conn (Drs Butler and De Camilli).


RELATED ARTICLES

Paraneoplastic Neurological Syndromes: Paraneoplastic or Neurological?
Hassan M. Fathallah-Shaykh
Arch Neurol. 1999;56(2):151-152.
EXTRACT | FULL TEXT  

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(2):254-255.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Recommended diagnostic criteria for paraneoplastic neurological syndromes
Graus et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:1135-1140.
ABSTRACT | FULL TEXT  

Adult paraneoplastic opsoclonus-myoclonus syndrome associated with antimitochondrial autoantibodies
Blaes et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:1595-1596.
FULL TEXT  

Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome
Wessig et al.
Neurology 2003;61:195-198.
ABSTRACT | FULL TEXT  

Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies: A clinical and electrophysiological study of 20 patients
Camdessanche et al.
Brain 2002;125:166-175.
ABSTRACT | FULL TEXT  

Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients
Gultekin et al.
Brain 2000;123:1481-1494.
ABSTRACT | FULL TEXT  

Paraneoplastic Neurological Syndromes: Paraneoplastic or Neurological?
Fathallah-Shaykh
Arch Neurol 1999;56:151-152.
FULL TEXT  

Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins. FURTHER CHARACTERIZATION OF THE NUCLEOCYTOPLASMIC beta -N-ACETYLGLUCOSAMINIDASE, O-GlcNAcase
Wells et al.
J. Biol. Chem. 2002;277:1755-1761.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.